These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 34452337)

  • 1. Influenza Vaccine Effectiveness in Preventing Severe Outcomes in Patients Hospitalized with Laboratory-Confirmed Influenza during the 2017-2018 Season. A Retrospective Cohort Study in Catalonia (Spain).
    Acosta L; Soldevila N; Torner N; Martínez A; Ayneto X; Rius C; Jané M; Domínguez A; The Influenza Surveillance Network Of Catalonia Pidirac
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012-2015.
    Thompson MG; Pierse N; Sue Huang Q; Prasad N; Duque J; Claire Newbern E; Baker MG; Turner N; McArthur C;
    Vaccine; 2018 Sep; 36(39):5916-5925. PubMed ID: 30077480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS Network).
    Nichols MK; Andrew MK; Hatchette TF; Ambrose A; Boivin G; Bowie W; Chit A; Dos Santos G; ElSherif M; Green K; Haguinet F; Halperin SA; Ibarguchi B; Johnstone J; Katz K; Lagacé-Wiens P; Langley JM; LeBlanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Poirier A; Powis J; Richardson D; Schuind A; Semret M; Shinde V; Smith S; Smyth D; Stiver G; Taylor G; Trottier S; Valiquette L; Webster D; Ye L; McNeil SA;
    Vaccine; 2018 Apr; 36(16):2166-2175. PubMed ID: 29548608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of influenza illness by seasonal influenza vaccination status among hospitalised patients in four South American countries, 2013-19: a surveillance-based cohort study.
    Regan AK; Arriola CS; Couto P; Duca L; Loayza S; Nogareda F; de Almeida WAF; Antman J; Araya S; Avendaño Vigueras MA; Battaglia Paredes SC; Brstilo IF; Bustos P; Fandiño ME; Fasce R; Giovacchini CM; González Caro CI; von Horoch M; Del Valle Juarez M; Katz N; Olivares MF; da Silva DA; da Silva ET; Sotomayor V; Vergara N; Azziz-Baumgartner E; Ropero AM
    Lancet Infect Dis; 2023 Feb; 23(2):222-232. PubMed ID: 36206790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza.
    Castilla J; Godoy P; Domínguez A; Martínez-Baz I; Astray J; Martín V; Delgado-Rodríguez M; Baricot M; Soldevila N; Mayoral JM; Quintana JM; Galán JC; Castro A; González-Candelas F; Garín O; Saez M; Tamames S; Pumarola T;
    Clin Infect Dis; 2013 Jul; 57(2):167-75. PubMed ID: 23532475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccine effectiveness against hospitalization with laboratory-confirmed influenza in Greece: A pooled analysis across six seasons, 2013-2014 to 2018-2019.
    Mouratidou E; Lambrou A; Andreopoulou A; Gioula G; Exindari M; Kossyvakis A; Pogka V; Mentis A; Georgakopoulou T; Lytras T
    Vaccine; 2020 Mar; 38(12):2715-2724. PubMed ID: 32033848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Prior Season Vaccination on Subsequent Influenza Vaccine Effectiveness to Prevent Influenza-related Hospitalizations Over 4 Influenza Seasons in Canada.
    Nichols MK; Andrew MK; Ye L; Hatchette TF; Ambrose A; Boivin G; Bowie W; Dos Santos G; Elsherif M; Green K; Haguinet F; Katz K; Leblanc J; Loeb M; MacKinnon-Cameron D; McCarthy A; McElhaney JE; McGeer A; Powis J; Richardson D; Semret M; Sharma R; Shinde V; Smyth D; Trottier S; Valiquette L; Webster D; McNeil SA;
    Clin Infect Dis; 2019 Aug; 69(6):970-979. PubMed ID: 30508064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of influenza B severe hospitalized cases during 10 seasons in Catalonia: Does the lineage make a difference?
    Soldevila N; Basile L; Martínez A; Torner N; Marcos MÁ; Mosquera MDM; Antón A; Andrés C; Rius C; Pumarola T; Domínguez Á;
    J Med Virol; 2022 Sep; 94(9):4417-4424. PubMed ID: 35593301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study.
    Casado I; Domínguez Á; Toledo D; Chamorro J; Astray J; Egurrola M; Fernández-Sierra MA; Martín V; Morales-Suárez-Varela M; Godoy P; Castilla J;
    CMAJ; 2018 Jan; 190(1):E3-E12. PubMed ID: 29311098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.
    Mira-Iglesias A; López-Labrador FX; Guglieri-López B; Tortajada-Girbés M; Baselga-Moreno V; Cano L; Mollar-Maseres J; Carballido-Fernández M; Schwarz-Chavarri G; Díez-Domingo J; Puig-Barberà J;
    Euro Surveill; 2018 Feb; 23(8):. PubMed ID: 29486829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus.
    Martínez-Baz I; Navascués A; Pozo F; Chamorro J; Albeniz E; Casado I; Reina G; Cenoz MG; Ezpeleta C; Castilla J;
    Hum Vaccin Immunother; 2015; 11(7):1626-33. PubMed ID: 25996366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza Vaccination Modifies Disease Severity Among Community-dwelling Adults Hospitalized With Influenza.
    Arriola C; Garg S; Anderson EJ; Ryan PA; George A; Zansky SM; Bennett N; Reingold A; Bargsten M; Miller L; Yousey-Hindes K; Tatham L; Bohm SR; Lynfield R; Thomas A; Lindegren ML; Schaffner W; Fry AM; Chaves SS
    Clin Infect Dis; 2017 Oct; 65(8):1289-1297. PubMed ID: 28525597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12.
    Castilla J; Martínez-Baz I; Martínez-Artola V; Reina G; Pozo F; García Cenoz M; Guevara M; Morán J; Irisarri F; Arriazu M; Albéniz E; Ezpeleta C; Barricarte A; ;
    Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons.
    Domínguez A; Castilla J; Godoy P; Delgado-Rodríguez M; Saez M; Soldevila N; Astray J; Mayoral JM; Martín V; Quintana JM; González-Candelas F; Galán JC; Tamames S; Castro A; Baricot M; Garín O; Pumarola T;
    Hum Vaccin Immunother; 2013 Apr; 9(4):865-73. PubMed ID: 23563516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study.
    Grijalva CG; Feldstein LR; Talbot HK; Aboodi M; Baughman AH; Brown SM; Casey JD; Erickson HL; Exline MC; Files DC; Gibbs KW; Ginde AA; Gong MN; Halasa N; Khan A; Lindsell CJ; Nwosu SK; Peltan ID; Prekker ME; Rice TW; Shapiro NI; Steingrub JS; Stubblefield WB; Tenforde MW; Patel MM; Self WH;
    Clin Infect Dis; 2021 Oct; 73(8):1459-1468. PubMed ID: 34014274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of influenza vaccination in preventing hospitalisation in children in Western Australia.
    Blyth CC; Cheng AC; Finucane C; Jacoby P; Effler PV; Smith DW; Kelly H; Macartney KK; Richmond PC
    Vaccine; 2015 Dec; 33(51):7239-7244. PubMed ID: 26549359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine effectiveness of live attenuated and trivalent inactivated influenza vaccination in 2010/11 to 2015/16: the SIVE II record linkage study.
    Simpson CR; Lone NI; Kavanagh K; Englishby T; Robertson C; McMenamin J; Wissman BV; Vasileiou E; Butler CC; Ritchie LD; Gunson R; Schwarze J; Sheikh A
    Health Technol Assess; 2020 Dec; 24(67):1-66. PubMed ID: 33256892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.
    Hellenbrand W; Jorgensen P; Schweiger B; Falkenhorst G; Nachtnebel M; Greutélaers B; Traeder C; Wichmann O
    BMC Infect Dis; 2012 May; 12():127. PubMed ID: 22650369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term effectiveness of adjuvanted influenza A(H1N1)pdm09 vaccine in children.
    Örtqvist Å; Bennet R; Hamrin J; Rinder MR; Lindblad H; Öhd JN; Eriksson M
    Vaccine; 2015 May; 33(22):2558-61. PubMed ID: 25869891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.